Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133346) titled 'Intelligent Imaging Interpretation System for Ovarian Cancer Bowel Metastasis' on Sept. 24.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Intestinal Metastases from Ovarian Cancer
Intervention:
Gold Standard:Intraoperative findings and postoperative pathology of the patient
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Target condition:3000;Difficult condition:500
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?p...